Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Checkmate Pharmaceuticals
3168
Checkmate Pharmaceuticals
Technology
Biotechnology
Health Care
Medical
Medical Devices
Checkmate Pharmaceuticals, a Cambridge, MA-based clinical stage biotechnology company with a novel approach to cancer immunotherapy.
Suggest edits
Founded
2015
Raised
$134M
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Xconomy
Biogen
Money Mover
HubSpot
Formlabs
Akamai
General Catalyst
Companies in the same industry
MediBeacon
Signostics
Daktari Diagnostics
NICO
IsoPlexis
Apama Medical
EIT Emerging Implant Technologies GmbH
NanoCellect Biomedical
AxioMed, LLC
CortiCare
Alexa global traffic share
Overview
Funding
3
Add info
Latest funding
Show all
$85,000,000
Venture capital (Series C) - 2020
Omega Funds
Longitude Capital
Sectoral Asset Management
+8
$22,000,000
Venture capital (Series C) - 2018
Team Size
1–10
Employees
I work here
Location
Cambridge
,
United States
Headquarters
Explore Cambridge
$85,000,000
Venture capital (Series C)
FinSMEs
,
Pulse 2.0
Checkmate Pharmaceuticals Raises $85M in Series C Financing
$22,000,000
Venture capital (Series C)
FinSMEs
Checkmate Pharmaceuticals Closes $22M Financing
$27,000,000
Venture capital (Series B)
businesswire
,
PE HUB
,
ENDPOINTS NEWS
Checkmate Pharmaceuticals Secures $27 Million Series B Preferred Financing and Appoints Karen Brennan as Chief Operating...